Inosita Plus ( Sitagliptin + Metformin HCl)

Net Weight:

Shelf Life:

Inosita Plus tablets contain two oral hypoglycemic drugs used in the management of Type II diabetes: Sitagliptin phosphate monohydrate and Metformin hydrochloride. Sitagliptin is an orally-active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme.

Reviews

There are no reviews yet.

Be the first to review “Inosita Plus ( Sitagliptin + Metformin HCl)”

Your email address will not be published. Required fields are marked *